SEC Form 3 · accession 0001065949-15-000180
CANNAPHARMARX, INC. · CPMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert M Liess
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 13, 2015 · 7:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001081938
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 800,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to the June 29, 2015 closing of the merger contemplated by the Amended and Restated Agreement and Plan of Merger dated April 21, 2105, all of the issued and outstanding capital stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share, of the Issuer. Mr. Liess received 800,000 shares pursuant to the merger.